The effects of clinical decision support system for prescribing medication on patient outcomes and physician practice performance: a systematic review and meta-analysis by Taheri Moghadam, S. et al.
Taheri Moghadam et al. 
BMC Med Inform Decis Mak           (2021) 21:98  
https://doi.org/10.1186/s12911-020-01376-8
RESEARCH ARTICLE
The effects of clinical decision support 
system for prescribing medication on patient 
outcomes and physician practice performance: 
a systematic review and meta-analysis
Sharare Taheri Moghadam1, Farahnaz Sadoughi2* , Farnia Velayati1, Seyed Jafar Ehsanzadeh3 
and Shayan Poursharif4
Abstract 
Background: Clinical Decision Support Systems (CDSSs) for Prescribing are one of the innovations designed to 
improve physician practice performance and patient outcomes by reducing prescription errors. This study was there-
fore conducted to examine the effects of various CDSSs on physician practice performance and patient outcomes.
Methods: This systematic review was carried out by searching PubMed, Embase, Web of Science, Scopus, and 
Cochrane Library from 2005 to 2019. The studies were independently reviewed by two researchers. Any discrepancies 
in the eligibility of the studies between the two researchers were then resolved by consulting the third researcher. In 
the next step, we performed a meta-analysis based on medication subgroups, CDSS-type subgroups, and outcome 
categories. Also, we provided the narrative style of the findings. In the meantime, we used a random-effects model to 
estimate the effects of CDSS on patient outcomes and physician practice performance with a 95% confidence inter-
val. Q statistics and  I2 were then used to calculate heterogeneity.
Results: On the basis of the inclusion criteria, 45 studies were qualified for analysis in this study. CDSS for prescription 
drugs/COPE has been used for various diseases such as cardiovascular diseases, hypertension, diabetes, gastrointes-
tinal and respiratory diseases, AIDS, appendicitis, kidney disease, malaria, high blood potassium, and mental diseases. 
In the meantime, other cases such as concurrent prescribing of multiple medications for patients and their effects on 
the above-mentioned results have been analyzed. The study shows that in some cases the use of CDSS has beneficial 
effects on patient outcomes and physician practice performance (std diff in means = 0.084, 95% CI 0.067 to 0.102). It 
was also statistically significant for outcome categories such as those demonstrating better results for physician prac-
tice performance and patient outcomes or both. However, there was no significant difference between some other 
cases and traditional approaches. We assume that this may be due to the disease type, the quantity, and the type of 
CDSS criteria that affected the comparison. Overall, the results of this study show positive effects on performance for 
all forms of CDSSs.
Conclusions: Our results indicate that the positive effects of the CDSS can be due to factors such as user-friendliness, 
compliance with clinical guidelines, patient and physician cooperation, integration of electronic health records, CDSS, 
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Background
The health care industry is influenced by factors that 
increase costs and reduce the quality of health services 
[1]. One such consideration is the prescribing errors 
and drug interactions that are common among medi-
cal errors; hence, there is no need to note that avoiding 
such errors is of the utmost importance in preventing 
the side effects of drugs and other related consequences 
[2]. One of the most important medical errors that can 
lead to morbidity, mortality, and prolonged hospital stay 
is an inappropriate prescription medication [3]. Owing to 
a lack of clear documentation of medical history as well 
as data recording and reporting systems, the primary 
explanation for most prescription errors is insufficient 
knowledge about patients or their drugs [4]. The Clinical 
Decision Support System (CDSS) technology is also com-
monly used in the field to decrease prescription errors 
through reminders and alerts; meanwhile, it improves 
physician performance and patient outcomes [5]. On the 
basis of patient circumstances, CDSS is used to coordi-
nate complex activities from initiation to monitoring and 
completion of medical care as well as providing guidance 
to physicians [6].
Various types of CDSS systems based on clinical 
guidelines, alerts, reminders, instructions, and recom-
mendations are included in this study. For instance, the 
alert-based type of CDSS uses reminders and drug inter-
action alerts [7]. CDSS benefits involve reducing pre-
scribing errors by using alerts and immediate reminders, 
automated dosing error checks, and drug interactions. 
E-prescribing systems with support for clinical decision-
making have the potential to decrease errors and improve 
clinical practice [8]. The assessment of the effects of all 
computerized health care interventions is important 
in managing the health care process and patient out-
comes [9]. Over the past years, a number of systematic 
studies have been conducted with the goal of analyzing 
the effect of CDSSs on prescription errors or CPOEs on 
patient safety, the care process, or the performance of 
physicians. In 2003, a systematic review of the two major 
databases revealed a reduction in drug errors due to the 
use of CDSS; however, the specifics of the findings have 
not been disclosed [10]. Another systematic review was 
also conducted in 2008 with an emphasis on the effects 
of CPOEs on medication errors. The results of this study 
showed a decrease in risk failure errors in 23 out of 25 
included studies. While demonstrating the effectiveness 
of CPOEs, this research did not explain the outcome of 
the patients [11]. In the same way, another systematic 
review examined the effect of CDSS on prescribing errors 
in 2010. Since this analysis omitted the Randomized 
Controlled Trial (RCT) tests, the findings indicated a 
small change in the patient outcome. However, there 
has been a significant improvement in the care outcome 
process [3]. In another study in 2015, a review of the sys-
tematic reviews of the CDSS on patient safety was con-
ducted. The results of this study showed improvement in 
outcomes. However, the authors argued that they need to 
include more studies with greater data pools in order to 
be able to further validate the CDSSs effect on outcomes 
[12]. In this systematic review, the most recent sample 
was collected in 2014 on a limited medication labora-
tory domain for some particular diseases [13]. In addi-
tion, another systematic study was carried out in 2017 to 
evaluate the effects of various forms of alerts on patient 
safety and medical outcomes. Surprisingly, the findings 
of the study showed no significant difference between 
various types of alerts except for some interrupting alerts 
that did not contribute to any improvement in outcomes 
[14]. CPOE was used for pediatrics in another system-
atic study whose purpose was to determine the errors. 
Results of this study demonstrated the usefulness of the 
system [15].
Considering the literature we have reviewed so far, 
the results of most studies have indicated the efficacy of 
CDSS compared to conventional clinical practices. The 
literature on CDSS has also shown progress in the phy-
sicians’ efficiency; however, the effect of these programs 
on patient outcomes is still uncertain [3, 16–18]. Due 
to the fact that CDSSs have been verified as useful tools 
to reduce prescribing errors, we decided to consider all 
types of CDSSs for all diseases and patients since 2005. 
Given the importance of CDSSs, in the present study, we 
examine the effects of CDSSs on physician prescribing 
performance and patient outcomes.
Methods
We used a systematic review and meta-analysis in this 
study. The method section is divided into a variety of 
subsections, including search strategy, inclusion/exclu-
sion criteria, screening and data extraction, quality 
assessment, data synthesis, and statistical analysis. Each 
subsection is described in more detail, as follows.
and pharmaceutical systems, consideration of the views of physicians in assessing the importance of CDSS alerts, and 
the real-time alerts in the prescription.
Keywords: Computerized clinical decision support systems, Medication prescription, Systematic review
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Search strategy
The initial search was performed in PubMed to iden-
tify the keywords. We used Medical Subject Head-
ings (MeSH) in PubMed, Emtree in Embase, and other 
words/phrases used in related papers as the basis 
for a search strategy. The major search was then con-
ducted in PubMed, Embase, Web of Science, Scopus, 
and Cochrane Library. We performed the search in 
2018 and used an approach tailored for each database 
without any language restrictions. Alerts were used to 
access published papers after the search date, and all 
database alerts were checked until July 2019. Reference 
tracking and citation search were also used to improve 
the retrieval of eligible studies. An example of the com-
plete search strategy is given below:
(("clinical decision support system*" OR "clinical 
Decision Support*" OR "computerized decision sup-
port tool*" OR "Information System*" OR "computer-
ized physician order entry*" OR "hospital information 
system*" OR "computerized medical record system*" 
OR "point-of-care system*" OR "medical order entry 
system*" OR "computer-assisted decision making" OR 
"computerized medical record system*" OR "reminder 
system*" OR "computer-assisted diagnosis" OR "clinical 
informatics*")) AND ("medical mistake*" OR "medical 
error*" OR "therapeutic error*" OR "diagnostic error*" 
OR "drug interaction*" OR "drug dose–response rela-
tionship" OR "drug administration schedule" OR "drug 
monitoring").
Registration number on PROSPERO is 
CRD42018079936 [19].
Inclusion/exclusion criteria
We used the PICO criterion to conduct the search strat-
egy: Participants (P) were individual practitioners or 
graduate trainees (e.g. medical residents); intervention (I) 
was any form of CDSS/CPOE system applied to the pre-
scribing process; comparator (C) were those papers that 
used other systems or did not use any system; outcome 
(O) was any patient outcomes and physician performance 
outcomes. In this study, we included randomized CDSS 
clinical trial papers such as alert-based, recommenda-
tion-based, instruction-based, and reminder-based sys-
tems to assess their effects on patients and providers. In 
selecting a paper for this study, we first prepared a list of 
questions whose answers form the key criterion for inclu-
sion as follows:
• Does the research concentrate on assessing the pre-
scribing CDSS/CPOE based on any category of 
patient outcomes and physician performance out-
comes?
• Is the study a randomized clinical trial in which the 
patient care was compared with and without pre-
scribing CDSS/CPOE?
• Have experts such as physicians, specialists, and resi-
dents used the CDSS for prescribing CPOE in these 
studies?
• Does the decision support system/CPOE evaluate 
patient-specific information in the form of manage-
ment or likelihood choices or recommendations for 
physicians?
• Has the practice been identified as a measure of the 
improved care process or the outcome of patients 
with any improvement in the study?
We excluded non-experimental studies as well as the 
studies in which the system was used exclusively by stu-
dents who were not experts, or "no" was given as the 
answer to these five main questions.
Screening and data extraction
The papers were screened in three separate steps based 
on title, abstract, and full text. In the meantime, we used 
the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) checklist as a report-
ing guide-line in our study. The results of the search are 
shown in Fig.  1. PRISMA checklist is a well-established 
standardized checklist for systematic review studies [20]. 
The evaluation was carried out by two authors of this 
study (S.T) and (F.V). The selection, screening, and data 
extraction phases were independently performed to pre-
vent bias. Any differences between researchers have been 
resolved by consulting an expert in this field (F.S). The 
data extracted from the included studies are first author, 
year of publication, country, and type of disease, design 
of the study, intervention, and type of intervention, num-
ber of centers/providers/patients, patient outcomes, pro-
vider outcomes, outcome impact, and statistical output.
Quality assessment
We assessed the quality of studies by Jadad scale, the 
Oxford research methods scoring system for bias in clini-
cal trials [21, 22]. We also determined the quality score by 
adding total scores for each sample. Meanwhile, we used 
zero and one for the exclusion/inclusion of items such as 
randomization, blindness, removal, dropouts, inclusion 
criteria, assessment of findings, and explanation of the 
statistical analysis.
Data synthesis and statistical analysis
We extracted data from qualified articles using a struc-
tured data extraction method. The findings of the stud-
ies were presented in a descriptive-narrative form. In 
the meantime, we have conducted a meta-analysis with 
Page 4 of 26Taheri Moghadam et al. BMC Med Inform Decis Mak           (2021) 21:98 
Comprehensive Meta-Analysis (CMA) statistical tools 
[23]. For all the analyzed data, the assessments of both 
the CDSS and the control groups were summarized as 
the mean standard deviation for each study and the com-
parison of pooled estimates between the intervention 
group and the control group. An effect size of std diff in 
the means of change in outcomes between groups was 
presented as standard error and 95% CI. The size of the 
effect with a lower limit greater than 0 implies that the 
intervention group has a positive effect on the outcome. 
The CDSS group does not affect the outcome compared 
to the control group when the lower limit is less than 0. 
Also, when std diff in means equals 0, it means that the 
change in outcomes was similar between the CDSS and 
the control groups. Meta-analysis using a random-effects 
model was performed to predict physician practice per-
formance and patient outcomes. We used Q statistics 
and I2 to calculate heterogeneity (I2 greater than 50% is 
considered heterogeneous). Sensitivity analysis was also 
conducted to define and reduce the sources of heteroge-
neity. In the next step, the funnel plot was used to assess 
publication bias. A funnel plot is a valuable method for 
assessing potential visual publication bias [24].
Results
On the basis of the inclusion criteria, we selected 45 qual-
ified articles (Fig. 1). The assessment of the studies pro-
vided us with valuable information on the research goals, 
Records idenfied through database 
searching
(n =  1207 )
PubMed: 150     Cochrane: 80 


























Records excluded with tle
(n =522)
Full-text arcles assessed 
for eligibility
(n = 104)
Records excluded with 
abstract
(n = 338)
Studies included in 
qualitave synthesis
(n = 45) 
Full-text arcles excluded, 
with reasons
(n = 65) 
Duplicate arcle
(n = 243)
Arcles find by alert
(n =6)
Fig. 1 The PRISMA flow diagram of selected studies. The number of records for each database is specified. The PRISMA theory approach is also 
displayed in the blue rectangles
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the types of electronic prescription systems, the types of 
diseases, and patients. Table 1 indicates that the findings 
of the quality evaluation of the studies were appropriate.
The findings also demonstrated the effectiveness of 
CDSS in many diseases such as cardiovascular disease, 
high blood pressure, and diabetes, or cases such as simul-
taneous prescription of drugs. Findings from the ana-
lyzed studies are presented in Table 2 in which * stands 
for p values indicating a statistically significant difference.
The number of studies based on multiple evaluation 
results and types of studies is also shown in Figs. 2 and 
3, respectively. Table  2 shows the variety of outcomes 
for several medication scopes (for example, the outcome 
"Increasing the ratio of prescribing prophylaxis" is spe-
cific for cardiovascular domain, or the outcome "Reduc-
ing blood pressure" is related to hypertension disorders). 
Meanwhile, Table  2 shows various kinds of CDSSs for 
prescribing classified according to alerts, reminders, rec-
ommendations, instruction, and a combination of these 
types. Table  2 also briefly presents the outcome of the 
thirteen medication scopes involved.
The effect of CDSS on cardiovascular diseases
For patients admitted to the hospital, the level of venous 
thromboembolism prophylaxis, and the proportion of 
prescribed prophylaxis increased during 6–24  h after 
admission [25]. In another study, the discrepancies 
among physicians over the thromboprophylaxis treat-
ment decreased with the aid of CDSS by offering treat-
ment recommendations (p = 0.02) [26]. In other studies, 
alert-based CDSSs have positive effects on physician per-
formance and treatment improvement in anti-inflamma-
tory and lipid-lowering drugs [28, 29, 31]. By following 
medical recommendations in another study, physicians in 
the intervention group were able to improve the prescrib-
ing level of secondary preventive medication through 
using a regular CDSS [30]. Also, in other trials, the short 
messages of the program had a positive effect on patient 
adherence to medication and diet (p < 0.01) [32, 33].
The effect of CDSS on hypertension
In one study, the electronic monitoring and recall pro-
gram had no effect on blood pressure reduction and the 
admission of patients [34]. However, in another study, the 
patient outcome improved following the implementation 
of the CDSS [35].
The effect of CDSS on diabetes
In some studies, the Real-Time Medication Monitor-
ing (RTMM) system, equipped with a short message 
reminder, improved the precision of patients’ compliance 
and missed dose [36, 37, 39, 40]. In another study, HbA1c 
and group differences were greater in the intervention 
group using recommendation CDSS than that of the 
control group [38]. The use of statins (p = 0.03) and the 
problem areas in diabetes (PAID) (p = 0.01) improved in 
another study for the intervention group that used CDSS 
[37].
The effect of CDSS on digestive diseases
In all studies, the CDSS had an effect on prescribing non-
steroidal anti-inflammatory drugs, proton pump inhibi-
tors, and increasing the standard use of oral rehydration 
solution without any difference in other results [41–43]. 
Also, alert-based CDSS improved the quality of patient 
care in another study [42].
The effect of CDSS on pulmonary diseases
In some trials, the use of CDSS which was integrated 
with electronic health record or prediction rules resulted 
in a decrease in the prescribing of antibiotics and mac-
rolides; therefore, it helped minimize the inappropriate 
use of antibiotics (p = 0.0005), reduce the resistance to 
antibiotics (p = 0.04), and enhance primary care [44–47, 
49]. The patients adhered to the reminder message in 
another study; however, the messages did not affect the 
success rate of therapy [48].
The effect of CDSS on AIDS
Results of this study showed that the reminder system for 
short text messages had a positive effect on the treatment 
process. Also, the number of messages did not have a 
significant effect on patients’ compliance rates (p = 0.12) 
[50].
The effect of CDSS on appendicitis
This study showed that the system’s systematically devel-
oped order set, which used clinical guidelines, improved 
system usability (p = 0.05), and reduced system-related 
problems (p = 0.05). This is the result of Computerized 
Provider Order Entry (CPOE) which improved efficiency, 
quality, and safety [51].
The effect of CDSS on kidney diseases
One study showed the positive effect of the multipurpose 
intervention on creatinine value estimation and dose 
adjustment to reduce the insufficient dosage of primary 
care drugs [53]. In another study, the appropriate pre-
scription rate for kidney problems was low, as opposed to 
the results of the former study. Also, the effectiveness of 
the CDSS with physician guidelines has been improved 
[52].
The effect of CDSS on taking multiple medications
In one study, CDSSs resulted in delayed drug treatment 
for four patients needing urgent treatment. This suggests 
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Table 1 Quality assessment for trials
References Was research 
described as 
randomized?




























Beeler et al. 
[25]
1 0 0 0 1 0 1 1 4
Eckman et al. 
[26]
1 1 0 0 1 1 1 1 6
Du et al. [27] 1 1 1 1 1 1 1 1 8
Karlsson et al. 
[28]
1 1 1 1 1 1 1 1 8
Mazzaglia 
et al. [29]
1 1 1 1 1 0 1 1 7
Nielsen et al. 
[30]
1 1 1 1 1 1 1 1 8
Patel et al. 
[31]
1 1 0 0 1 1 1 1 6
Akhu-zaheya 
et al. [32]
1 1 0 0 0 1 1 1 5
Khonsari et al. 
[33]
1 1 0 0 0 0 1 1 4
Christensen 
et al. [34]
1 1 1 1 1 1 1 1 8
Luitjes et al. 
[35]
1 1 1 1 0 1 1 1 7
Buhse et al. 
[36]
1 1 0 0 1 0 1 1 5
Perestelo-
pérez et al. 
[37]
1 1 0 0 1 1 1 1 6
Sáenz et al. 
[38]
1 1 1 1 1 1 1 1 8
Vervloet et al. 
[39]
1 1 1 1 0 0 1 1 6
Vervloet et al. 
[40]
1 1 1 1 0 1 1 1 7
Geurts et al. 
[41]
1 1 0 0 1 0 1 1 5
Gill et al. [42] 1 1 0 0 1 1 1 1 6
Petersen et al. 
[43]
1 1 1 1 1 1 1 1 8
Bourgeois 
et al. [44]
1 1 1 1 1 1 1 1 8
Juszczyk et al. 
[45]
1 1 1 1 1 0 1 1 7
Mcdermott 
et al. [46]
1 1 1 1 1 1 1 1 8
Mcginn et al. 
[47]
1 1 0 0 1 1 1 1 6
Mohammed 
et al. [48]
1 1 1 1 0 1 1 1 7
Ackerman 
et al. [49]
1 1 0 0 1 0 1 1 5
Pop-eleches 
et al. [50]
1 1 0 0 1 1 1 1 6
Avansino 
et al. [51]
1 1 1 1 1 0 1 1 7
Awdishu et al. 
[52]
1 1 1 1 1 1 1 1 8
Erler et al. [53] 1 1 1 1 1 1 1 1 8
Cox et al. [54] 1 1 0 0 1 0 1 1 5
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that the adverse effects of these systems need to be evalu-
ated and monitored [56]. In another study, the CDSS 
improved the primary dose of medication, time inter-
vals for drug use, and drug concentration which is to be 
injected intravenously compared to standard doses [54]. 
Also in another study, the average number of readmission 
days for each patient and the combination of re-hospital-
ization and emergency ward visits within 30  days after 
hospital discharge did not vary between the intervention 
group using recommendation CDSS and control groups 
[58]. In some trials, there was no discrepancy between 
the outcomes of the dosage rate and the Modified Medi-
cation Appropriateness Index (MMAI).
In the meanwhile, no discrepancy was seen among 
improper medication prescribing (p = 0.48), the Medica-
tion Regimen Complexity Index, and the mean pain out-
come difference after 6 months (p = 0.13) and 9 months 
(p = 0.78) between the intervention group using alert or 
reminder CDSS and the control group [55, 57].
The effect of CDSS on Malaria
The use of text-messaging in one study did not affect the 
patients’ behavior in completing the course of medication 
for the full duration of treatment. However, when the 
side effects were low (p = 0.02), it had some effects on the 
continuous use of the medication. In addition, text mes-
sages had an effect on physicians’ knowledge about the 
use of medications with fatty foods. (p < 0.0001) [59].
The effect of CDSS on increasing the level of blood 
potassium
In one study, there is no statistical difference between 
the control and intervention groups in terms of following 
1 stands for the answer “yes”, and 0 stands for the answer “no”
Table 1 (continued)
References Was research 
described as 
randomized?




























Muth et al. 
[55]
1 1 1 1 1 1 1 1 8
Strom et al. 
[56]
1 1 0 0 1 1 1 1 6
Strom et al. 
[57]
1 1 1 1 1 1 1 1 8
Elliott et al. 
[58]
1 1 1 1 0 0 1 1 6
Bruxvoort 
et al. [59]
1 1 1 1 0 1 1 1 7
Beeler et al. 
[60]
1 1 1 1 1 1 1 1 8
Duke et al. 
[61]
1 1 1 1 1 1 1 1 8
Eschmann 
et al. [62]
1 1 1 1 1 0 1 1 7
Curtain et al. 
[5]
1 1 0 0 1 1 1 1 6
Turchin et al. 
[6]
1 1 0 0 1 1 1 1 6
Griffey et al. 
[63]
1 1 0 0 1 1 1 1 6
Myers et al. 
[64]
1 1 1 1 1 1 1 1 8
Van Stiphout 
et al. [65]
1 1 1 1 1 1 1 1 8
Willis et al. 
[66]
1 1 1 1 0 1 1 1 7
Tamblyn et al. 
[67]
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alerts and patients’ compliance rate. However, the physi-
cians’ compliance rate improved at the medium potas-
sium level from 3 to 3.9 (mili-equivalents/liter) (p < 0.01) 
[61]. Due to the rapid response of physicians to pro-
gram alerts for high potassium levels in the intervention 
group, the positive effect of the system on physician per-
formance was evident in another study (p = 0.01) [62]. 
However, in another study in this section, the time-lapse 
in hyperkalemia monitoring (p = 0.20) and the incidence 
rate of hyperkalemia (p = 0.22) did not vary significantly 
even with the use of three different kinds of reminder and 
alert-based CDSSs [60].
The effect of CDSS on medication prescription for patients
Based on the results of some studies, the regular or alert 
based CDSSs resulted in better drug prescriptions for the 
proton pump inhibitor and a reduction in abbreviation 
prescriptions [5, 64]. Also, in other studies, the overall 
utilization of system functionalities, system utilization 
between two-time laps (p < 0.0001), number of users 
(p < 0.0001), and physicians’ compliance with the medica-
tion recommendations provided by the CDSS improved 
medication prescriptions which eventually resulted in 
reduced side effects (p = 0.02) [6, 63]. There was no dif-
ference in prescribing among physicians in one study 
(p = 0.14); however, the percentage of skilled questions 
for the intervention group equipped with training CDSS 
(p = 0.01) improved [65]. In another study, alert-based 
CDSSs have been effective in identifying evidence-based 
pharmacotherapies (EBP). In the meantime, compliance 
with treatment by health care managers has had no effect 
on patient outcome [66].
The effect of CDSS on mental disorders
CDSS alerts resulted in reduced risk of injury and 
reduced dose of antipsychotics and anticoagulants 
(p = 0.03) over a one-year period. Therefore, CDSS 
reduced the risk of injury (p = 0.02) [67].
Statistical and sensitivity analysis
The pooled std diff in means of p values showed a signifi-
cant difference between the CDSS and the control group 
(std diff in means = 0.091, 95% CI 0.072–0.109, standard 
error = 0.010). 95% CI for the effectiveness was drawn 
for each study in the horizontal line format (Q = 209.2, 
df = 45, p = 0.0002, I2 = 78.492, Tau2: 0.004) (Fig. 4). Due 
to the high heterogeneity of results, a sensitivity analy-
sis was performed. In doing so, we excluded the follow-
ing studies: khonsari et  al. [33]; Ackerman et  al. [49]; 
Avansino et al. [51], and Bruxvoort et al. [59]. Because of 
the limited number of patients in these trials, we decided 
to exclude them from our meta-analysis. In Tables 2 and 
3, the characteristics of these studies are presented in 
narrative results. The findings indicate that heterogeneity 
improved considerably after sensitivity analysis (Fig.  5). 
(Q = 164.8, df = 41, p = 0.0001, I2 = 75.136, Tau2: 0.003). 
The overall effect of CDSS for prescribing medications 
on patient outcomes and physician practice performance 
based on the random-effects model was statistically sig-
nificant (std diff in means = 0.84, 95% CI 0.067–0.102).
Subgroup analysis for medication scope
Figure 5 shows the results of the meta-analysis for each 
subgroup of medication scope and the total analysis. 
Subgroup analysis is performed on different medication 
groups because there have been common outcomes in 
related similar medication scope studies. The subgroup 
analysis showed a significant difference between CDSS 






Both patient outcome and physician behavior
Fig. 2 The number of studies based on several evaluating outcomes. 
The number of studies that assessed different kinds of outcomes 
based on patient outcomes, physician performance, or both 
outcomes is identified
Fig. 3 The number of studies based on the type of included studies. 
The number of studies focused on different types of randomized 
controlled trials has been established
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as hypertension: (std diff in means = 0.187, 95% CI 
0.102–0.272); increasing blood potassium: (std diff in 
means = 0.036, 95% CI 0.006–0.066), multiple medica-
tions: (std diff in means = 0.208, 95% CI 0.084–0.332), 
AIDs: (std diff in means = 0.241, 95% CI 0.038–0.444), 
kidney disorders: (std diff in means = 0.133, 95% CI 
0.073–0.193), diabetes: (std diff in means = 0.381, 95% 
CI 0.223–0.539), cardiac: (std diff in means = 0.073, 
95% CI 0.035–0.111), mental diseases: (std diff in 
means = 0.062, 95% CI 0.010–0.114), medication pre-
scription for patients: (std diff in means = 0.157, 95% 
CI 0.094–0.219), and pulmonary diseases: (std diff in 
means = 0.079, 95% CI 0.014–0.144). However, there 
was no significant difference between the interven-
tion and control group for digestive diseases: (std diff 
in means = 0.182, 95% CI − 0.072 to 0.437). Figure  5 
shows the forest plot for subgroup meta-analysis. How-
ever, we eliminated malaria and appendicitis diseases 
due to the decrease of heterogeneity among studies. 
We then described malaria and appendicitis diseases 
in narrative results. Also, Figs. 6 and 7 show the num-
ber of studies associated with each country and type of 
CDSS.
Categorization of outcomes
Physician practice performance and patient outcomes 
are presented in Table 3 as primary outcomes are cate-
gorized based on the summary of the outcome concept 
and the impact of CDSS. Improvement or neutrality in 
outcomes is shown by plus or zero in Table 3. We cat-
egorized outcomes because similar outcomes may have 
different impacts on various diseases. For instance, the 
outcome “decrease prescribing” may have a positive 
effect on some diseases and no effect on other medica-
tion domains.
Fig. 4 Forest plot of the overall effect of CDSS for prescribing on physician practice performance and patient outcome based on medication 
subgroup analysis. Meta-analysis is conducted using Comprehensive Meta-Analysis (CMA) statistical tools. The pooled std diff in means of p values 
showed a significant difference between the CDSS and the control group (std diff in means = 0.091, 95% CI 0.072–0.109, standard error = 0.010). 
Confidence Interval (CI) represents for the linear area between lower and upper limits
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Table 3 Outcome classification for trials
References Primary outcome Outcome summarization Outcome 
impact
Outcome category
Beeler et al. [25] Increasing the ratio of prescribing prophylaxis 
6–24 h after admission/transfer
Increasing prescribing + Physician practice 
performance 
improvedEckman et al. [26] Reducing disagreement among physicians Reducing disagreement among 
physicians
+
Du et al. [27] Increasing secondary preventive prescriptions 
after 15 months in the intervention group
Increasing prescribing +
Karlsson et al. [28] Increasing the prescription of anticoagulation 
after 12 months
Increasing prescribing +
Mazzaglia et al. [29] Increasing prescription of anti-blocking drugs Increasing prescribing +
Patel et al. [31] Increasing the number of anti-inflammatory/
lipid-lowering drugs
Increasing prescribing +
Perestelo-pérez et al. [37] Increasing satisfaction of decision making Increasing satisfaction of decision 
making
+
Sáenz et al. [38] Increasing long-term blood sugar using 
between group differences
Increasing prescribing +
Geurts et al. [41] Increase in standard use of oral rehydration 
solution
Increasing prescribing +
Petersen et al. [43] Increase in drug prescription in patients with 
risk above 5 percent
Increasing prescribing +
Bourgeois et al. [44] Reduced antibiotic prescriptions in visits by 
using templates
Reducing prescribing +
Juszczyk et al. [45] Reducing unnecessary prescription of antibiot-
ics
Reducing prescribing +
Mcdermott et al. [46] Increasing physicians self-efficacy Increasing physicians efficacy +
Mcginn et al. [47] Reduced antibiotic prescription Reducing prescribing +
Avansino et al. [51] Increase in following clinical guidelines for 
systematic prescriptions compared to case 
prescriptions
Increase in following clinical guide-
lines
+
Awdishu et al. [52] Increase in not taking medication or changing 
dose of inadequate drugs
Reducing prescribing +
Erler et al. [53] Reduction in the amount of medication 
received in the intervention group in excess of 
the prescribed dose
Reducing prescribing +
Cox et al. [54] Increase in the number of prescriptions for 
initial drug use
Increasing prescribing +
Strom et al. [56] Increasing the percentage of appropriate alerts 
that have been responded to by physicians 
in the intervention group compared to the 
control group
Increasing the percentage of appro-
priate alerts
+
Beeler et al. [60] Increase in the average monitoring time of 
potassium level
Increase in the average monitoring 
time of potassium level
+
Eschmann et al. [62] Decrease in the reaction time to reminders in 
physicians for monitoring alerts for potassium 
level
Decrease in the reaction time to 
reminders
+
Curtain et al. [5] Reduction in the approved percentage of 
inhibitor intervention proton pump which is 
registered by the pharmacologist
Reduction in the approved percent-
age of inhibitor intervention 
proton pump which is registered 
by the pharmacologist
+
Turchin et al. [6] Increasing overall efficiency of system function-
alities prior to admission
Increasing overall efficiency of 
system functionalities
0
Griffey et al. [63] Increasing the number of prescriptions by rec-
ommending the determined system dose
Increasing prescribing +
Myers et al. [64] Reducing the significant number of inappropri-
ate abbreviations
Reducing prescribing +
Van Stiphout et al. [65] More efficient medical summary More efficient medical summary +
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Evaluation for publication bias
We conducted a funnel plot and Egger’s regression to 
evaluate the publication bias regarding the effect of CDSS 
on patient outcomes and physician performance [68, 69]. 
There was no significant difference with respect to pub-
lication bias (std diff in means = 0.054, CI 95%: 2.116 
to 2.941, p = 0.000001). Figure  8 depicts that the X-axis 
shows std diff in mean in the funnel diagram, and the 
Y-axis reflects standard error.
Discussion
The aim of this systematic review is to establish the 
effect of CDSS on patient outcomes and physician per-
formance. The effect of CDSS was measured using dif-
ferent methods in the included studies. In most cases, 
the effect of these programs on physician performance 
and patient outcomes were positive. In others, however, 
no significant effect has been found.
The results show that the use of CDSSs in cardiovas-
cular patients has positive effects on physician perfor-
mance by increasing the prescription of anticoagulants, 
Table 3 (continued)
References Primary outcome Outcome summarization Outcome 
impact
Outcome category
Akhu-zaheya et al. [32] Increasing prescriptions in the short message 
group
Increasing prescribing + Patient outcome 
improved
Khonsari et al. [33] Increasing adherence to drug usage Increasing adherence +
Vervloet et al. [39] Increasing adherence in the group receiving 
short messages
Increasing adherence +
ervloet et al. [40] Increasing the drug dosage in one hour during 
a six month period
Increasing prescribing +
Elliott et al. [58] Reducing the average number of days re-
hospitalized 60 days after discharge
Reducing the average number of 
days re-hospitalized
+
Bruxvoort et al. [59] Knowledge of the physician in using Lumefan-
trine or thometer
Increased Knowledge of the physi-
cian
+
Tamblyn et al. [67] Reduction in dose of drugs after one year for 
antipsychotics
Reducing prescribing +
Luitjes et al. [35] For the control group, reducing the secondary 
outcome of infant morbidity after implemen-
tation
Reducing morbidity + Physician practice 
performance and 
patient outcome 
improvedAckerman et al. [49] Reducing excess prescription of antibiotics Reducing prescribing +
Pop-eleches et al. [50] Reducing the number of treatment inter-
ruptions in both groups receiving weekly 
messages
Effective in process of care +
Christensen et al. [34] Reducing blood pressure after 12 months Reducing morbidity 0 Physician practice 
performance not 
improved
Nielsen et al. [30] Increasing the time outcome in the scope of 
treatment
Increasing the time outcome 0
Buhse et al. [36] Reduction in faulty knowledge causing risk Reducing risk 0
Gill et al. [42] Increase in receiving care on the basis of 
instructions for patients with low-dose aspirin 
use (25%)
Increase in receiving care 0
Muth et al. [55] Ineffectiveness of drug prescriptions after 6 and 
9 months
Ineffectiveness in process of care 0
Strom et al. [57] Reduction in the appropriate response of physi-
cians to alerts during 17 months
Reduction in the appropriate 
response of physicians to alerts
0
Duke et al. [61] Decrease in the conformity rate in normal risk 
patients for increased potassium
Decrease in the conformity rate in 
normal risk patients
0
Willis et al. [66] Lack of difference in the rate of patient adher-
ence to treatment, drug treatment signifi-
cance, economic and clinical outcomes in 
three groups
No difference in process of care 
outcomes
 + Patient outcome not 
improved
Mohammed et al. [48] Inability to be effective in treatment success 
rate
Ineffectiveness in process of care 0
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anti-inflammatory drugs, anti-thrombotic drugs, lipid-
lowering drugs, blood pressure drugs, cardiovascular 
drugs recommended for the reduction of cardiovas-
cular diseases in patients with diabetes, and observ-
ing clinical guidelines [25, 27–29]. The results of the 
current study are consistent with the results of Duke 
et al. and Brokel et al. in reducing inadequate prescrip-
tions and enhancing the process of observing clinical 
guidelines [61, 70]. Also, the system’s user-friendliness 
environment and low running cost have resulted in its 
efficiency in the care delivery process [25, 27–29].
However, the results of our study have shown that 
using CDSSs for cardiac patients did not affect the phy-
sician performance in a number of outcomes such as 
physician conduct in prescribing drugs, the Warfarin 
treatment system, reducing frustration with antithrom-
botic diagnostic guidelines, and job satisfaction [26, 
29–31]. The results of this study are also consistent 
Fig. 5 Forest plot of the overall effect of CDSS for prescribing on physician practice performance and patient outcome based on medication 
subgroup analysis after sensitivity analysis. After sensitivity analysis, heterogeneity improved considerably, excluding khonsari et al. [33]; Ackerman 
et al. [49]; Avansino et al. [51], and Bruxvoort et al. [59]. The pooled std diff in means of p values was used for evaluating the overall and subgroup 
effects of CDSS which were significantly different (std diff in means = 0.084, 95% CI 0.067–0.102) as a whole. Meta-analysis results for each subgroup 
of medication scope showed a significant difference between CDSS and control groups for medication scopes namely as hypertension (CI 0.102–
0.272); increasing blood potassium (CI 0.006–0.066); multiple medications (CI 0.084–0.332); AIDs (CI 0.038–0.444); kidney disorders (CI 0.073–0.193); 
diabetes (CI 0.223–0.539); cardiac (CI 0.035–0.111); mental disease (CI 0.010–0.114); medication prescription (CI 0.094–0.219); and pulmonary disease 
(CI 0.014–0.144)


























Fig. 6 The number of studies associated with each country. The number of studies carried out in different countries is identified
Fig.7 The number of studies associated with each CDSS type. The number of studies that were performed on various types of CDSS such as 
reminders and alarms is listed
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with Byrnes and Lazaro studies in that clinical factors 
and treatment issues were the reasons for physicians’ 
disagreement with system recommendations [71, 72]. 
The key explanation why there was no improvement in 
medical guidance is the complexity of clinical problems 
that could increase the risk of injury to the patient and 
delay the decision-making process [26, 29–31].
Also, the results of this study indicate that the use of 
CDSSs in cardiovascular patients has a positive effect on 
a number of outcomes such as adherence to drug use by 
patients and following a nutrition-based diet in the Medi-
terranean [32, 33]. Similarly, according to clinical guide-
lines and reminders, Schedlbauer et  al.’s study reported 
the positive effect of CDSS on cardiovascular patient 
outcomes [73]. The reason for poor adherence to the 
Mediterranean diet was the delivery of a short message 
outlining the advantages of the Mediterranean diet which 
resulted in an improved conformity level [32, 33].
The study also showed that the use of CDSS in cardi-
ovascular patients did not affect patient outcomes such 
as readmission rate, mortality, and smoking cessation 
[32, 33]. Similarly, the findings of Simpson et  al.’s study 
indicate that accurate compliance with the Short Mes-
sage System (SMS) reduces mortality risk and improves 
health outcomes [74]. One of the reasons for the negli-
gible reduction in mortality is the short duration of the 
study, small sample size, and inability to identify causes 
of mortality [32, 33]. Also, study results show that the 
use of CDSS in patients with hypertension in adherence 
to clinical guidelines and laboratory tests has a positive 
effect on physician performance [35]. Zwart et al.’s study, 
which is consistent with the results of our study, assessed 
the impact of CDSS on adherence to clinical guidelines. 
The study reported effective results about the treatment 
of pregnant women with hypertensive disorders [75]. In 
addition, physicians’ awareness of special care during 
pregnancy for hypertension resulted in improved patient 
care and adherence to CDSS [35].
Based on the results of this research, the use of CDSS 
in diabetic patients has a positive effect on physician per-
formance in a variety of outcomes such as adjusting the 
form of insulin and improving the quality of decision-
making about statin prescription [36–38]. The findings 
of Den Ouden et  al.’s and Mann et  al.’s studies are also 
consistent with the results of our review which suggest 
physicians’ strong adherence to CDSS, enhanced statin 
prescribing, and improved quality of medical care [76, 
77]. In fact, the CDSS dynamically recommends the insu-
lin dose based on the rounds of previous days, the type 
of insulin injected, and the glucose level of the patient on 
the day before [36–38].
The results of this study indicate that the use of CDSS 
in diabetic patients has a positive effect on a variety 
of patient outcomes such as adherence to the nutri-
tional diet of patients with type 2 diabetes and taking 
the missed dose of medication [39, 40]. Meanwhile, the 
results of this study are consistent with Vervloet et  al.’s 
and Krishna et  al.’s systematic review on the positive 
Fig. 8 Funnel plot of standard error by std diff in means. There was no significant difference for publication bias for the included studies (p 
value = 0.000001). X-axis shows std diff in mean in the funnel diagram and the Y-axis reflects standard error. Dispersion of studies in the funnel plot 
showed that there was no bias in publication
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effect of CDSS with alerts on patients with diabetes [78, 
79]. The main reason for the effect of CDSS on improv-
ing patient adherence seems to be due to the fact that it 
raises patients’ awareness of taking medication [39, 40].
Also, the results of this study show that the use of 
CDSS in digestive disorders has a positive effect on the 
physician performance in a variety of outcomes such as 
the standard use of oral rehydration solution, the pre-
scription of non-steroidal anti-inflammatory drugs and 
proton pump inhibitors in normal and high-risk patients, 
and the provision of care services in line with the guide-
lines for primary care [41–43]. The results of this study 
are also consistent with the findings of Nicastro’s study 
which stated that the system had positive effects on phy-
sician performance such as adherence to clinical guide-
lines and prescription of drugs [80]. The reason for the 
positive effect of CDSS on the prescription of non-steroi-
dal anti-inflammatory drugs and proton pump inhibitors 
in high-risk patients and the use of oral rehydration solu-
tion was the systems’ recommendations about the above-
mentioned drugs [41–43].
The results of this study also showed that the use of 
CDSS in respiratory patients had a positive effect on 
physician performance and reduced antibiotic prescrip-
tion [44–47, 49]. The results of this study are therefore 
consistent with the findings of Mcdermott et  al.’s and 
Butler et  al.’s results on the positive effect of CDSS on 
the self-efficacy of physicians in managing chronic res-
piratory patients and reducing the prescription of antibi-
otics [81, 82]. We think that the reason for the system’s 
positive effect on the self-efficacy of physicians was their 
tendency to cooperate on decision-making and not to 
receive mandatory CDSS recommendations [44–47, 49].
With respect to respiratory patients, the results of this 
study show that the use of CDSS has a positive effect 
on some patient outcomes such as reduced antibiotic 
resistance and a reduction in antibiotic prescription [48, 
49]. Similarly, the results of Hebert et al.’s and Steinman 
et al.’s studies show reduced resistance to antibiotics [83, 
84]. We conclude that the patient-physician partnership 
with the CDSS guideline, which played a significant role 
in the prescribing of medicines, was the explanation for 
the positive effect of CDSS on the reduction of irrational 
antibiotic prescription and resistance [48, 49].
With respect to appendicitis, the results of our review 
indicate that the use of CDSS has a positive effect on 
physician performance in certain outcomes such as per-
formance, quality, and safety with the assistance of physi-
cians’ computerized order entry [51]. The results of this 
review are in line with Holden’s study which explores 
how physicians using the order entry system would 
receive more up-to-date information and boost the sys-
tem’s capabilities [85]. Although prescriptions are not 
strong in terms of content, errors are decreased as CPOE 
encourages physicians to consider cases [51].
Also, the results show that the use of CDSS in kidney 
patients has a positive effect on physicians’ performance 
in some outcomes such as reduced dosage of inade-
quately prescribed drugs and the improved rate of ade-
quate prescription [52, 53]. Such findings are consistent 
with Bates et al.’s and Chertow et al.’s studies which show 
the positive effect of CDSS alerts on modifying insuf-
ficient prescriptions and increasing the recommended 
level of inadequate dosage [86, 87]. The timeline of CDSS 
alerts was the main reason for the positive impact of 
CDSS on the prescription and recommended dosage of 
drugs [52, 53].
Based on the results of our review, the use of CDSS 
in patients with high blood potassium levels has a posi-
tive effect on physicians’ performance in some outcomes 
such as the faster physicians’ response in the intervention 
group to system alerts and reminders [62]. is study are 
also consistent with Helmous et  al.’s and Paterno et  al.’s 
reports which show that physicians’ adherence to alerts 
improved by 19 percent [88, 89]. The key explanation for 
the positive effect of CDSS on physician performance 
was uninterrupted alerts and reminders [62].
Results of the study showed that the use of CDSS in 
prescribing drugs for patients has a positive effect on 
physician performance in certain outcomes such as drug 
prescription for proton pump inhibitors, CDSS produc-
tivity and usability, reduction of drug side effects, and 
improving the learning rate and physicians’ skills [5, 6, 
63–65]. The results of this study are consistent with the 
results of Curtis and Shah et  al.’s study indicating that 
relevant CDSS, while providing users with performance-
related information, reduces patients’ harms and errors, 
and increases physicians’ knowledge and skills [90, 91]. 
One of the main reasons for the proton pump’s enhanced 
medication performance was the control of prescription 
drug dose by physicians as well as equipping pharma-
cies with CDSS with hard alerts which reduce costs and 
improve usability [5, 6, 63–65].
Results show that the use of CDSS in prescribing a 
number of drugs has a positive effect on physician per-
formance in some outcomes such as the number of emer-
gency ward visits, the number of re-hospitalizations, and 
determination and supervision of the number of drugs 
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including the initial dose [54, 58]. The results are con-
sistent with Vincent and Cordero’s study which demon-
strates that combining the computerized order entry 
process with an alert system saves time in prescribing 
and optimizing the dosage of drugs [92, 93]. The reason 
for CDSS’ positive effect on the number of re-hospitaliza-
tions, emergency ward visits, and reduced morbidity rate 
was due to the fact that CDSS had a knowledge base in 
pharmacogenetics and was equipped with drug interac-
tion alerts [54, 58].
Analysis of the results of the reviewed studies shows 
that the use of CDSS in prescribing a number of drugs 
has no effect on the physician performance in outcomes 
such as drug prescription rates with drug suitability 
index, average functional status outcome, and drug com-
plexity index [55–57]. The results of our study are con-
sistent with Olsson’s study which shows that CDSS for 
elderly people, who use multiple types of medicines, has 
no effect on important outcomes [94]. We conclude that 
the unexpected findings of our review may be due to the 
lack of information about patients with serious infec-
tions who require immediate care and the lack of an effi-
cient checklist monitoring the patients’ drug problems 
[55–57].
The most critical CDSS system factors for outcome 
improvement are: alignment of guidelines with registered 
and EHR data to make decisions about each individual 
patient [29, 31, 33]; the short massages that include only 
necessary alerts such as drug interaction alerts sent in 
the right time for prescribing and user-friendly interface 
for saving physicians’ time [18, 20, 44, 45, 47, 48]; giving 
the choice to users by enabling them to close the alert 
window and move through next steps or provide unin-
terrupted alerts [37–41, 56]; the behaviors of physicians 
and patients which have positive effects on outcomes 
in CDSS-equipped environments through collabora-
tion, following guidance, recommendations, alerts, and 
reminders that the system provides [37, 42]. Also, consid-
ering physician perception in defining the importance of 
alerts helps better understand the interruption status of 
alerts [37–41].
Subgroup analysis for CDSS types
The subgroup analysis for various CDSS types showed 
a significant relationship between CDSS and con-
trol group for alerts: (std diff in means = 0.134, 95% 
CI 0.082–0.0187); combination types of CDSSs: (std 
diff in means = 0.197, 95% CI 0.022–0.372); recom-
mendation CDSSs: (std diff in means = 0.114, 95% CI 
0.063–0.166); reminders: (std diff in means = 0.131, 95% 
CI 0.072–0.189); and instructional CDSSs: (std diff in 
means = 0.129, 95% CI 0.081–0.178). Figure 9 shows the 
forest plot for CDSS types.
Outcome analysis
Figure  10 shows the results of meta-analysis for out-
come categories and the total analysis. The pooled std 
diff in means of p values did not show a significant dif-
ference between CDSS and the control group (std 
diff in means = 0.0110, 95% CI 0.086–0.138, standard 
error = 0.013). 95% CI for the effectiveness was drawn 
for each study in the horizontal line format (Q = 209.2, 
df = 45, p = 0.0003, I2 = 78.492, Tau2: 0.004). The findings 
indicate that heterogeneity improved considerably after 
sensitivity analysis (Fig. 11). (Q = 164, df = 41, p = 0.0002, 
I2 = 75, Tau2: 0.003). After this change, the overall effects 
of clinical decision support system for prescribing on 
patient outcomes and physician practice performance 
based on the random effect model was significantly dif-
ferent: (std diff in means = 0.114, 95% CI 0.090–0.138).
The outcome analysis showed a significant difference 
between CDSS and control groups for the categoriza-
tion of outcomes. Results showed that patient outcome 
improved: (std diff in means = 0.435, 95% CI 0.122–
0.747); physician practice performance improved: (std 
diff in means = 0.105, 95% CI 0.78–0.133); physician 
practice performance and patient outcome improved: 
(std diff in means = 0.196, 95% CI 0.111–0.281); physi-
cian practice performance didn’t improve: (std diff in 
means = 0.131, 95% CI 0.040–0.222). The outcome analy-
sis did not confirm a significant difference between CDSS 
and control groups for the category of patient outcome: 
(std diff in means = 0.064, 95% CI − 0.038 to 0.165).
The CDSS types that have enhanced the outcome for 
patients or physician practice are as follows: alerts, rec-
ommendations, instructional CDSSs, reminders, and a 
combination of all of them. Patient outcomes and prac-
tice performance outcomes have been improved with the 
use of the CDSSs for prescribing. In some trials, however, 
the CDSS was not specifically related to patient outcomes 
and showed only a marginal improvement in medical 
practice outcomes.
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Limitations and implications for research
Although we conducted a meta-analysis on the outcomes 
based on subgroup analysis, the heterogeneity among the 
included studies in our analysis prevented us from using 
sturdier mix methods. The effect that we expected of the 
system as a whole was statistically significant. Since we 
used the main outcome data for meta-analysis of the tri-
als, there could be other outcomes by choosing certain 
secondary outcomes that are not statistically different 
from our findings. Further outcomes can be obtained by 
Fig. 9 Forest plot of the effect of CDSS for prescribing on physician practice performance and patient outcome based on subgroup analysis for 
CDSS types. The subgroup analysis for various CDSS types showed a significant difference for alerts (CI 0.082–0.0187); combination types of CDSSs 
(CI 0.022–0.372); recommendation CDSSs (CI 0.063–0.166); reminders (CI 0.072–0.189); and instructional CDSSs (0.081 to 0.178). The results are 
assessed following the exclusion of khonsari et al. [33]; Ackerman et al. [49]; Avansino et al. [51] and Bruxvoort et al. [59] studies
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extending the spectrum of all kinds of CDSSs in addition 
to CDSS for prescribing.
Conclusion
This systematic review study was conducted with the 
aim of identifying the effect of CDSS on patient out-
comes and physician performance. The results show that 
the use of CDSS in some diseases has positive effects on 
patient outcomes and physician performance while it 
has no significant effect on others. In addition, the types 
of outcomes and the effects of CDSS on the diseases are 
different. In some cases, the use of this approach yields 
positive outcomes for patients and physicians; however, 
in some other cases, it shows no significant difference 
compared to conventional approaches. The positive 
effect of CDSS seems to be attributed to factors such 
as the user-friendliness of the system, the number of 
patients requiring treatment, the rate of observance of 
clinical guidelines, the conformity of clinical guidelines 
and data registry, the rate of patients’ accurate adherence 
to messages of the system, the usefulness of short mes-
sages, the existence of algorithms with dynamic func-
tioning based on patient data, the existence of patient 
medical records, the relationship between electronic 
health records with CDSS and timely alerts of the system 
in the prescribing process. In addition, the positive effect 
of CDSS depends on a number of other factors such as 
providing an instruction section, not being confronted 
with mandatory recommendations, patient and physi-
cian cooperation with the aid of CDSS guidelines, not 
lagging between alerts where the alert is of low impor-
tance, the identification of important alerts, equipping 
pharmacies with CDSS and system applicability, and 
Fig. 10 Forest plot of the overall effect of CDSS for prescribing on physician practice performance and patient outcome based on outcome 
categorization. The pooled std diff in the mean p values did not indicate a significant difference between the CDSS and the control group before 
the sensitivity analysis was performed (std diff in means = 0.0110, 95% CI 0.086–0.138, standard error = 0.013)
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considering the opinions of physicians when assessing 
the value of alerts for drug interaction.
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